Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics

키워드

참고문헌 (100)

1. Apweiler, R, "On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database", Biochim. Biopys. Acta, 1473, pp.4~8 (1999)
2. Taniguchi, N, "A glycomic approach to the identification and characterization of glycoprotein function in cells transfected with glycosyltransferase genes", Proteomics, 1, pp.239~247 (2001)
3. Taniguchi, N, "Functional glycomics and evidence for gain- and loss-of-functions of target proteins for glycosyltransferases involved in N-glycan biosynthesis: their pivotal roles in growth and development, cancer metastasis and antibody therapy against cancer proceedings of the Japan Academy", Series B, 통권 : 80, pp.82~91 (2004)
4. Taniguchi, N, "Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor", Glycoconj. J, 18, pp.859~865 (2001)
5. Taniguchi, N, "Implication of N-acetylglucosaminyltransferases III and V in Cancer: Gene regulation and signaling mechanism", Biochim. Biophys. Acta, 1473, pp.9~20 (1999)
6. Zhao, Y, "Branched N-glycans regulate the biological functions of integrins and cadherins", FEBS J, 275, pp.1939~1948 (2008)
7. Zhao, Y. Y, "Functional roles of N-glycans in cell signaling and cell adhesion in cancer", Cancer Sci, 99, pp.1304~1310 (2008)
8. Taniguchi,N, "From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises", J. Biol. Chem, 284, pp.34469~34478 (2009)
9. Schachter, H, "Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides", Biochem. Cell Biol, 64, pp.163~181 (1986)
10. Stanley, P, "N-Glycans; In Essentials of Glycobiology. 2nd ed", pp.101~114 (2009), Cold Spring Harbor Laboratory Press
11. Narasimhan,S, "Control of glycoprotein synthesis. UDP-GlcNAc: glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides", J. Biol. Chem, 257, pp.10235~10242 (1982)
12. Gleeson, P. A, "Oligosaccharide branching of glycoproteins: biosynthetic mechanisms and possible biological functions", J. Biol. Chem, 258, pp.6162~6173 (1983)
13. Taniguchi, N, "Gamma-Glutamyl transpeptidase: catalytic mechanism and gene expression", Adv. Enzymol. Related Areas Mol. Biol, 72, pp.239~278 (1998)
14. Yokosawa, N, "Physiochemical and immunochemical characterization of gamma-glutamyl transpeptidase from yolk sak tumor and ascitic hepatoma (AH-66) cells", Oncodev. Biol. Med, 2, pp.165~177 (1981)
15. Yamashita, K, "Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from rat liver and rat AH-66 hepatoma cells", Cancer Res, 43, pp.5059~5063 (1983)
16. Hase, S, "Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins", J. Biochem, 95, pp.197~203 (1984)
17. Nishikawa, A, "A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC", Anal. Biochem, 170, pp.349~354 (1988)
18. Taniguchi, N, "Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V", Methods Enzymol, 179, pp.397~408 (1989)
19. Nishikawa, A, "Determination of N-acetylglucosaminyltransferases III, IV and V in normal and hepatoma tissues of rats", Biochim. Biophys. Acta, 1035, pp.313~318 (1990)
20. Nishikawa, A, "Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: alpha-D-mannoside beta-1, 4N-acetylglucosaminyltransferase III from rat kidney", J. Biol. Chem, 267, pp.18199~18204 (1992)
21. Taniguchi, N, "Decoding sugar functions by identifying target glycoproteins", Curr. Opin. Struct. Biol, 6, pp.561~566 (2006)
22. Yoshimura, M, "Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection", Proc. Natl. Acad. Sci. U.S.A, 92, pp.8754~8758 (1995)
23. Yoshimura, M, "Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis", J. Biol. Chem, 271, pp.13811~13815 (1996)
24. Pinho, S. S, "Modulation of E-cadherin function and dysfunction by N-glycosylation", Cell Mol. Life Sci, 68, pp.1011~1020 (2010)
25. Iijima, J, "Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GEii epithelial cells. Involvement of E-cadherin-mediated cell adhesion", J. Biol. Chem, 281, pp.13038~13046 (2006)
26. 나오유키 타니구치, "FUNCTIONAL ROLES OF THE BISECTING GLCNAC IN INTEGRIN-MEDIATED CELL ADHESION", METHODS IN ENZYMOLOGY, VOL 480: GLYCOBIOLOGY Book Series: Methods in Enzymology, 480, pp.445~459 (2010), ELSEVIER ACADEMIC PRESS INC
27. Zhao, Y, "N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration", J. Biol. Chem, 281, pp.32122~32130 (2006)
28. Sato, Y, "An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III", J. Biol. Chem, 276, pp.11956~11962 (2001)
29. Kariya, Y, "Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3- dependent keratinocyte motility", J. Biol. Chem, 286, pp.4310~4318 (2010)
30. Sato, Y, "Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors", J. Biol. Chem, 276, pp.11956~11962 (2001)
31. Takahashi, M, "Role of N-glycans in growth factor signaling", Glycoconj. J, 20, pp.207~212 (2004)
32. Takahashi, M, "Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins", Carbohydr. Res, 344, pp.1387~1390 (2009)
33. Ihara, Y, "Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor", J. Biol. Chem, 272, pp.9629~9634 (1997)
34. Xu, Q, "Wnt", beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation, 2011, pp.286, 4310~4318
35. Shibukawa, Y, "Down-regulation of hydrogen peroxide- induced PKC delta activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells", J. Biol. Chem, 278, pp.3197~3203 (2003)
36. Li, W, "Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity", Glycobiology, 17, pp.655~662 (2007)
37. Yoshimura, M, "Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization", Cancer Res, 56, pp.412~418 (1996)
38. Gu, J, "beta1,4-N-Acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras", ERK signaling pathway in PC12 cells, 2004, pp.14, 177~186
39. Guo, H. B, "Opposing changes in N-acetylglucosaminyltransferase-V and -III during the cell cycle and all-trans retinoic acid treatment of hepatocarcinoma cell line", Biochim. Biophys. Acta, 1495, pp.297~307 (2000)
40. Koma, M, "Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases", Glycobiology, 10, pp.745~751 (2000)
41. Koyota, S, "Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc", J. Biol. Chem, 276, pp.32867~32874 (2001)
42. Komoda, H, "Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase- III (GnT-III) in cynomolgus monkeys", Xenotransplantation, (3), pp.209~216 (2005)
43. Oguri, S, "Purification and characterization of UDP-N-acetylglucosamine: alpha 1,3-D-mannoside beta 1,4- N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase- IV) from bovine small intestine", J. Biol. Chem, 272, pp.22721~22727 (1997)
44. Minowa, M. T, "cDNA cloning and expression of bovine UDP-N-acetylglucosamine: alpha1,3- D-mannoside beta1,4-N-acetylglucosaminyltransferase IV", J. Biol. Chem, 273, pp.11556~11562 (1998)
45. Yamashita, K, "Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver", J. Biochem, 1105, pp.728~735 (1989)
46. Endo, T, "Structural differences found in the asparaginelinked sugar chains of human chorionic gonadotropins purified from the urine of patients with invasive mole and with choriocarcinoma", Cancer Res, 47, pp.5242~5245 (1987)
47. Koenderman, A. H, "N-acetylglucosaminyltransferase III, IV and V activities in Novikoff ascites tumour cells, mouse lymphoma cells and hen oviduct. Application of a sensitive and specific assay by use of high-performance liquid chromatography", Eur. J. Biochem, 181, pp.651~655 (1989)
48. Nakao, H, "Modulation of N-acetylglucosaminyltransferase III, IV and V activities and alteration of the surface oligosaccharide structure of a myeloma cell line by interleukin 6", Biochem. Biophys. Res. Commun, 172, pp.1260~1266 (1990)
49. Ide, Y, "Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer", Biochem. Biophys. Res. Commun, 341, pp.478~482 (2006)
50. Ohtsubo, K, "Targeted genetic inactivation N-acetylglucosaminyltransferase- IVa impairs insulin secretion from pancreatic beta cells and evokes type 2 diabetes", Methods Enzymol, 479, pp.205~222 (2010)
51. Ohtsubo, K, "Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport", Nat. Med, 17, pp.1067~1075 (2011)
52. Takamatsu, S, "and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice", Glycobiology, 4, pp.485~497 (2010)
53. Shoreibah, M, "Isolation, characterization, and expression of a cDNA encoding N-acetylglucosaminyltransferase V", J. Biol. Chem, 268, pp.15381~15385 (1993)
54. Gu, J, "Purification and characterization of UDP-N-acetylglucosamine: alpha-6-Dmannoside beta 1-6N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase V) from a human lung cancer cell line", J. Biochem, 113, pp.614~619 (1993)
55. Granovsky, M, "Mgat5-deficient mice", Nat. Med, 6, pp.306~312 (2000)
56. Partridge, E. A, "Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis", Science, 306, pp.120~124 (2004)
57. Lau, K. S, "Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation", Cell, 129, pp.123~134 (2007)
58. Taniguchi, N, "Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor", Glycoconj. J, 18, pp.859~865 (2001)
59. Kang, R, "Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1", J. Biol. Chem, 271, pp.26706~26712 (1996)
60. Ko, J. H, "Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines", J. Biol. Chem, 274, pp.22941~22948 (1999)
61. Miyoshi, E, "Transforming growth factor beta up-regulates expression of the N-acetylglucosaminyltransferase V gene in mouse melanoma cells", J. Biol. Chem, 270, pp.6216~6220 (1995)
62. Guo, HB, "N-acetylglucosaminyltransferase V expression levels regulate cadherin- associated homotypic cell-cell adhesion and intracellular signaling pathways", J. Biol. Chem, 278, pp.52412~52424 (2003)
63. Sato, T, "Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells", J. Biol. Chem, 270, pp.6216~6220 (1995)
64. Zhang, W, "Regulation of expression of the human beta-1, 2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors", Biochem. J, 347(Pt 2), pp.511~518 (2000)
65. Ihara, S, "Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching", J. Biol. Chem, 277, pp.16960~16967 (2002)
66. Ihara, S, "Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin", Glycobiology, 14, pp.139~146 (2004)
67. Kataoka, H, "Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF", scatter factor, 2003, pp.22, 223~236
68. Santin, A. D, "The novel serine protease tumor-associated differentially expressed gene-15 (matriptase", MT-SP1) is highly overexpressed in cervical carcinoma, 2003, pp.98, 1898~1904
69. Saito, T, "A secreted type of beta 1, 6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity", J. Biol. Chem, 277, pp.17002~17008 (2002)
70. Nakahara, S, "A secreted type of beta1, 6 N-acetylglucosaminyltransferase V (GnT-V), a novel angiogenesis inducer, is regulated by gamma-secretase", FASEB J, 14, pp.2451~2459 (2006)
71. 나오유키 타니구치, "Enhanced Epithelial-Mesenchymal Transition-like Phenotype in N-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing", JOURNAL OF BIOLOGICAL CHEMISTRY, 286(32), pp.28303~28311, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
72. Kim, Y. S, "Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the Invasive", Metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1, 2008, pp.7, 1~14[DOI]
73. Inamori, K, "Molecular cloning and characterization of human GnT-IX, a novel beta1, 6-N-acetylglucosaminyltransferase that is specifically expressed in the brain", J. Biol. Chem, 278, pp.43102~43109 (2003)
74. Kaneko, M, "A novel beta(1,6)-N-acetylglucosaminyltransferase V (GnTVB)", FEBS Lett, 554, pp.515~519 (2003)
75. Inamori, K, "N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1, 2-Man alpha 1-Ser", Thr moiety, forming a 2, 6-branched structure in brain O-mannosyl glycan, 2004, pp.279, 2337~2340
76. Inamori, K, "High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis", FEBS Lett, 580, pp.627~632 (2006)
77. Inamori, K, "Demonstration of the expression and the enzymatic activity of N-acetylglucosaminyltransferase IX in the mouse brain", Biochim. Biophys. Acta, 60, pp.678~684 (2006)
78. 나오유키 타니구치, "Brain-specific Expression of N-Acetylglucosaminyltransferase IX (GnT-IX) Is Regulated by Epigenetic Histone Modifications", JOURNAL OF BIOLOGICAL CHEMISTRY, 286(36), pp.31875~31884, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
79. Chiba, A, "Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel Omannosyl- type oligosaccharide in the binding of alpha-dystroglycan with laminin", J. Biol. Chem, 272, pp.2156~2162 (1997)
80. Matsumura, K, "Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies", Muscle Nerve, 1, pp.2~15 (1994)
81. Toda, T, "Fukutin and alpha-dystroglycanopathies", Acta Myol, 24, pp.60~63 (2005)
82. Abbott, K. L, "Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding", J. Biol. Chem, 283, pp.33026~33035 (2008)
83. Oriol, R, "Divergent evolution of fucosyltransferase genes from vertebrates, invertebrates, and bacteria", Glycobiology, 9, pp.323~334 (1999)
84. Voynow, J. A, "Purification and characterization of GDP-L-fucose-Nacetyl beta-D-glucosaminide alpha 1-6fucosyltransferase from cultured human skin fibroblasts. Requirement of a specific biantennary oligosaccharide as substrate", J. Biol. Chem, 266, pp.21572~21577 (1991)
85. Uozumi, N, "Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-6fucosyltransferase", J. Biol. Chem, 271, pp.27810~27817 (1996)
86. Yanagidani, S, "Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells", J. Biochem, 121, pp.626~632 (1997)
87. Wang, X, "Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema- like phenotype in core fucose-deficient mice", Proc. Natl. Acad. Sci. U.S.A, 102, pp.15791~15796 (2005)
88. Yamada, M, "Association of fucosyltransferase 8 (FUT8) polymorphism Thr267Lys with pulmonary emphysema", J. Hum. Gen (2011)
89. Fukuda, T, "Alpha1, 6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems", J. Biol. Chem, 286, pp.18434~18443 (2011)
90. Aoyagi, Y, "The fucosylation index of alpha- fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma", Cancer, 61, pp.769~774 (1988)
91. Taketa, K, "A collaborative study for the evaluation of lectin-reactive alpha- fetoproteins in early detection of hepatocellular carcinoma", Cancer Res, 53, pp.5419~5423 (1993)
92. Nakagawa, T, "Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients", J. Proteome Res, 6, pp.2222~2233 (2008)
93. Okuyama, N, "Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation", Int. J. Cancer, 118, pp.2803~2808 (2006), a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.Int.J.Cancer 118,2803-2808.
94. Takeda, Y, "Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer", Cancer (2011)
95. Nakagawa, T, "Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts", J. Biol. Chem, 281, pp.29797~29806 (2006)
96. Shields, R. L, "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity", J. Biol. Chem, 277, pp.26733~26740 (2002)
97. Shinkawa, T, "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", J. Biol. Chem, 278, pp.3466~3473 (2003)
98. Ferrara, C, "Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose", Proc. Natl. Acad. Sci. U.S.A, 108, pp.12669~12674 (2011)
99. Mizushima, T, "Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans", Genes Cells, 11, pp.1071~1080 (2011)
100. Taniguchi, N, "From glycobiology to systems glycobiology: International network with Japanese scientists through consortia", IUBMB Life, 58, pp.1~4 (2006)

관련 논문AI추천